Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

TriSalus Life Sciences (TLSI) Shares Issued (2022 - 2026)

TriSalus Life Sciences has reported Shares Issued over the past 5 years, most recently at $32000.0 for Q1 2026.

For Q1 2026, Shares Issued changed N/A year-over-year to $32000.0; the TTM value through Mar 2026 reached $542000.0, down 95.47%, while the annual FY2025 figure was $510000.0, 96.62% down from the prior year.
Shares Issued for Q1 2026 was $32000.0 at TriSalus Life Sciences, down from $87000.0 in the prior quarter.
Over five years, Shares Issued peaked at $15.1 million in Q4 2024 and troughed at -$9.5 million in Q4 2023.
A 5-year average of $1.2 million and a median of $88000.0 in 2025 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: crashed 45104.76% in 2023 and later surged 259.67% in 2024.
Year by year, Shares Issued stood at $21000.0 in 2022, then crashed by 45104.76% to -$9.5 million in 2023, then surged by 259.67% to $15.1 million in 2024, then tumbled by 99.42% to $87000.0 in 2025, then crashed by 63.22% to $32000.0 in 2026.
Business Quant data shows Shares Issued for TLSI at $32000.0 in Q1 2026, $87000.0 in Q4 2025, and $88000.0 in Q3 2025.